Studies have shown that WNT5A regulates IL-6 expression in melanoma and modulates the expression of SASP factors in tendon stem cells, and that IL-6 exhibits a reciprocal regulation with CCL2 in non–small cell lung cancer (32, 33). Here, WNT5A is linked to melanoma.